Supplementary Material
S1. Proportion of positive screens for depressive disorders (PHQ-9 score ≥ 10)
Women Men
Age group Sample in % (95% CI) [n/N] General populationa in % [n/N] Sample in % [n/N] General populationa in % [n/N]
25-34 50 (6.8-93.2) [2/4] 5.3 (3.2-8.2) [18.6/351] 12.5 (0.3-52.6) [1/8] 4.5 (2.4-7.6) [12.6/279]
35-44 26.7 (7.8-55.1) [4/15] 5.8 (4-8.1) [31.4/542] 7.1 (0.2-33.9) [1/14] 4.4 (2.6-6.9) [17.4/396]
45-54 15.7 (7-28.6) [8/51]* 3 (1.6-5) [13.7/457]* 16.5 (9.5-25.7) [15/91]* 6.1 (4-8.9) [25.3/414]*
55-64 27.8 (17.9-39.6) [20/72]* 6.4 (4.3-9.1) [28.5/446]* 14.2 (9.3-20.4) [24/169] 7.8 (5.4-10.9) [31/398]
65-74 14.1 (7.5-23.4) [12/85] 8 (5.5-11.1) [31.6/395] 8.2 (4.7-13.2) [15/182] 7.2 (4.9-10.2) [28.6/397]
>74 25 (9.8-46.7) [6/24] 10.1 (6.6-14.7) [23.8/236] 5.3 (1.5-13.1) [4/75] 14.1 (9-20.6) [22/156]
Notes. Total N in study sample=790, only participants with valid responses included; a Prevalence estimate obtained from Kocalevent et al. [20]; *significant difference between study sample and general population with Bonferroni adjusted p-level: .05/[number of comparison: 8]= 0.006, age groups 25-34 and 35-44 not tested due to small subgroup size in study sample (n≤15).
S2. Proportion of positive screens for generalized anxiety disorders (GAD-7 score ≥ 10)
Women Men
Age group Sample in % (95% CI) [n/N] General populationa in % [n/N] Sample in % [n/N] General populationa in % [n/N]
25-34 75 (19.4-99.4) [3/4] 7.4 (5-10.5) [28.6/387] 0 (0-36.9) [0/8] 3.2 (1.5-5.9) [9.5/297]
35-44 40 (16.3-67.7) [6/15] 6.3 (4.4-8.6) [35.7/566] 7.1 (0.2-33.9) [1/14] 3.9 (2.2-6.3) [15.5/398]
45-54 10 (3.3-21.8) [5/50] 5.6 (3.7-8.1) [25.6/457] 12 (6.1-20.4) [11/92] 5.7 (3.6-8.4) [23.1/406]
55-64 21.1 (12.3-32.4) [15/71]* 6.9 (4.6-9.8) [28/406]* 10.7 (6.4-16.3) [18/169] 9.1 (6.5-12.4) [36.4/400]
65-74 7.1 (2.6-14.7) [6/85] 6.6 (4.3-9.6) [25.6/388] 6 (3-10.4) [11/184] 3.7 (2.1-6.1) [14.6/394]
>74 8.3 (1-27) [2/24] 6.6 (3.8-10.6) [15.4/234] 0 (0-4.8) [0/75] 6.4 (3-11.8) [9/141]
Notes. Total N study sample=791, only participants with valid responses included; a Prevalence estimate obtained from Löwe et al. [13]; *significant difference between study sample and general population with with Bonferroni adjusted p-level: .05/[number of comparison: 8]= 0.006, age groups 25-34 and 35-44 not tested due to small subgroup size in study sample (n≤15).
